tiprankstipranks
Promising Pipeline and Strategic Advancements: Marc Goodman Recommends ‘Buy’ for Belite Bio, Inc.
PremiumRatingsPromising Pipeline and Strategic Advancements: Marc Goodman Recommends ‘Buy’ for Belite Bio, Inc.
1M ago
Belite Bio’s Earnings Call: Cautious Optimism Amid Progress
Premium
Company Announcements
Belite Bio’s Earnings Call: Cautious Optimism Amid Progress
1M ago
Belite Bio Announces 2025 Annual Shareholder Meeting
Premium
Company Announcements
Belite Bio Announces 2025 Annual Shareholder Meeting
1M ago
Belite Bio Reports 2024 Financial Results and Clinical Progress
PremiumCompany AnnouncementsBelite Bio Reports 2024 Financial Results and Clinical Progress
1M ago
Belite Bio Releases 2024 Annual Report on Website
Premium
Company Announcements
Belite Bio Releases 2024 Annual Report on Website
1M ago
Belite Bio reports Q4 EPS (32c), consensus (31c)
Premium
The Fly
Belite Bio reports Q4 EPS (32c), consensus (31c)
1M ago
Belite Bio announces interim results from DRAGON trial
PremiumThe FlyBelite Bio announces interim results from DRAGON trial
2M ago
Belite Bio Announces $15 Million Direct Offering to Enhance Financial Position
Premium
Company Announcements
Belite Bio Announces $15 Million Direct Offering to Enhance Financial Position
2M ago
Belite Bio to sell 258,309 shares at $58.07 in registered direct offering
Premium
The Fly
Belite Bio to sell 258,309 shares at $58.07 in registered direct offering
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100